Literature DB >> 11287876

Unique epidemiology of nosocomial urinary tract infection in children.

J M Langley1, M Hanakowski, J C Leblanc.   

Abstract

BACKGROUND: Nosocomial urinary tract infection (NUTI) occurs with varying frequency in children and is thought to be associated with urethral instrumentation. In response to changing infection control resources at our facility, we reviewed NUTI to determine whether the frequency of NUTI, associated complications, or presence of a remediable risk factor (instrumentation) justified ongoing routine infection control surveillance.
METHODS: Prospective surveillance was conducted on all wards 8 months per year from January 1991 through December 1997 by an infection control nurse coordinator. NUTI was defined by laboratory evidence according to Center for Disease Control and Prevention definitions and detected 48 hours after admission. Urinary catheterization in the previous 7 days was categorized as continuous/indwelling or intermittent.
RESULTS: NUTI was the fifth most common nosocomial infection (129/1375; approximately 9%) and decreased in frequency during the decade from 0.9 to approximately 0.6 cases/1000 patient days. Incidence was equal among men and women. Only 50% of cases had prior instrumentation of the urinary tract. NUTI occurred disproportionately in newborns and infants (P <.001). The most common pathogen was Escherichia coli (28%; 38/132), followed by Candida sp (18%; 24/134), Enterococcus (13%; 18/134), gram-negative nonfermenters (13%; 17/132), Enterobacter (approximately 10%; 13/134), Pseudomonas (9.7%; 13/134), and other (16%; 22/134). Three cases of secondary bacteremia occurred (2.3%; 95% confidence interval 0.5-6.6); there was no mortality.
CONCLUSIONS: NUTI poses a less significant burden of illness (incidence, associated morbidity) than other nosocomial infection in children. If resources do not permit hospital-wide surveillance, high-risk children with urethral instrumentation and newborns and infants could be targeted. Although E coli remains the most common cause of pediatric NUTI, fungi have become the second most common pathogen in this tertiary care population. Risk factors for NUTI in noncatheterized children remain to be delineated.

Entities:  

Mesh:

Year:  2001        PMID: 11287876     DOI: 10.1067/mic.2001.111537

Source DB:  PubMed          Journal:  Am J Infect Control        ISSN: 0196-6553            Impact factor:   2.918


  13 in total

1.  Colistin resistance in Enterobacter spp. isolates in Korea.

Authors:  Yoon-Kyoung Hong; Ji-Young Lee; Kwan Soo Ko
Journal:  J Microbiol       Date:  2018-06-01       Impact factor: 3.422

2.  Community-acquired enterococcal urinary tract infections in hospitalized children.

Authors:  Nir Marcus; Shai Ashkenazi; Zmira Samra; Avner Cohen; Gilat Livni
Journal:  Pediatr Nephrol       Date:  2011-08-07       Impact factor: 3.714

3.  Community-acquired enterococcal urinary tract infections.

Authors:  Maria Bitsori; Sofia Maraki; Maria Raissaki; Anna Bakantaki; Emmanouil Galanakis
Journal:  Pediatr Nephrol       Date:  2005-06-22       Impact factor: 3.714

4.  Clinical significance of bacteriuria with low colony counts of Enterococcus species.

Authors:  R Colodner; T Eliasberg; B Chazan; R Raz
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-04       Impact factor: 3.267

5.  Development of a panel of recombinase polymerase amplification assays for detection of common bacterial urinary tract infection pathogens.

Authors:  B Raja; H J Goux; A Marapadaga; S Rajagopalan; K Kourentzi; R C Willson
Journal:  J Appl Microbiol       Date:  2017-08       Impact factor: 3.772

6.  Can we apply the European surveillance program of nosocomial infections (HELICS) to pediatric intensive care units?

Authors:  François Dubos; Marie Vanderborght; Anne-Laure Puybasset-Joncquez; Bruno Grandbastien; Francis Leclerc
Journal:  Intensive Care Med       Date:  2007-08-01       Impact factor: 17.440

7.  MrkH, a novel c-di-GMP-dependent transcriptional activator, controls Klebsiella pneumoniae biofilm formation by regulating type 3 fimbriae expression.

Authors:  Jonathan J Wilksch; Ji Yang; Abigail Clements; Jacinta L Gabbe; Kirsty R Short; Hanwei Cao; Rosalia Cavaliere; Catherine E James; Cynthia B Whitchurch; Mark A Schembri; Mary L C Chuah; Zhao-Xun Liang; Odilia L Wijburg; Adam W Jenney; Trevor Lithgow; Richard A Strugnell
Journal:  PLoS Pathog       Date:  2011-08-25       Impact factor: 6.823

Review 8.  Diagnosis, management, and prevention of catheter-associated urinary tract infections.

Authors:  Carol E Chenoweth; Carolyn V Gould; Sanjay Saint
Journal:  Infect Dis Clin North Am       Date:  2013-12-08       Impact factor: 5.905

Review 9.  Enterobacter aerogenes and Enterobacter cloacae; versatile bacterial pathogens confronting antibiotic treatment.

Authors:  Anne Davin-Regli; Jean-Marie Pagès
Journal:  Front Microbiol       Date:  2015-05-18       Impact factor: 5.640

10.  Transcriptional activation of the mrkA promoter of the Klebsiella pneumoniae type 3 fimbrial operon by the c-di-GMP-dependent MrkH protein.

Authors:  Ji Yang; Jonathan J Wilksch; Jason W H Tan; Dianna M Hocking; Chaille T Webb; Trevor Lithgow; Roy M Robins-Browne; Richard A Strugnell
Journal:  PLoS One       Date:  2013-11-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.